Status:
RECRUITING
Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-Project
Lead Sponsor:
University of Ulm
Conditions:
Acute Myeloid Leukemia (AML)
MDS/AML
Eligibility:
All Genders
18+ years
Brief Summary
This is a registry study in adult patients with newly diagnosed or refractory/relapsed myeloid neoplasms Investigator's sites: 80-90 sites in Germany and Austria Estimated duration of observation of...
Eligibility Criteria
Inclusion
- Patients with suspected diagnosis of acute myeloid leukemia and related neoplasms, newly diagnosed or relapsed/refractory, classified according to the International Consensus Classification
- Age ≥ 18 years. There is no upper age limit.
- Signed written informed consent
Exclusion
- Severe neurological or psychiatric disorder interfering with ability to give an informed consent
- No consent for registration, storage and processing of the individual patient and disease characteristics and course as well as information of the family physician about study participation
- No consent for biobanking of patient's biological specimens and performance of analyses on stored material.
Key Trial Info
Start Date :
July 6 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2044
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT01252485
Start Date
July 6 2010
End Date
December 31 2044
Last Update
January 5 2026
Active Locations (94)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Universität Graz
Graz, Austria, 8036
2
Medizinische Universität Innsbruck
Innsbruck, Austria, 6020
3
Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H.
Linz, Austria, 4010
4
Krankenhaus der Elisabethinen Linz GmbH
Linz, Austria, 4020